Evidence map›Paper›PMID 28878952›Full record

ArticleOpen heart

Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients.

Jodi McCoy, Matthew Bates, Christopher Eggett, Mario Siervo, Sophie Cassidy, Jane Newman, Sarah A Moore, Grainne Gorman, Michael I Trenell, Lazar Velicki and 5 more

Open access · goldAbstract read
In one paragraph

Article in Open heart. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Exercise capacity in RYR1-related myopathies.Orphanet journal of rare diseases · 2025
    Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Monitoring the Effects of Cardiac Rehabilitation Programs in Heart Failure Patients: The Role of Biomarkers.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Jodi McCoyInstitute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, UK.
Matthew BatesInstitute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, UK.
Christopher EggettInstitute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, UK.
Mario SiervoInstitute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, UK.
Sophie CassidyInstitute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, UK.
Jane NewmanInstitute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, UK.
Sarah A MooreInstitute of Neurosciences, Newcastle University, Newcastle upon Tyne, UK.
Grainne GormanInstitute of Neurosciences, Newcastle University, Newcastle upon Tyne, UK.
Michael I TrenellInstitute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, UK.
Lazar VelickiDepartment of Cardiovascular Surgery and Faculty of Medicine, Institute of Cardiovascular Diseases Sremska Kamenica, Novi Sad, Serbia.
Petar M SeferovicDepartment of Cardiology, Clinical Centre Serbia, University of Belgrade, Serbia, UK.
John G F ClelandDepartment of Cardiology, Imperial College Royal Brompton and Harefield Trust London, London, UK.
Guy A MacGowanDepartment of Cardiology, Freeman Hospital and Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Doug M TurnbullInstitute of Neurosciences, Newcastle University, Newcastle upon Tyne, UK.
Djordje G JakovljevicInstitute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, UK.
Newcastle University · GBInstitute for Cardiovascular Diseases of Vojvodina · RSRoyal Brompton & Harefield NHS Foundation Trust · GBRoyal Victoria Infirmary · GBUniversity of Belgrade · RSWellcome Centre for Mitochondrial Research · GB

Funding

Department of Health SRF-2011-04-017Medical Research Council G0700718Medical Research Council MR/L016354/1Medical Research Council MR/N007921/1Medical Research Council MR/P020941/1
6 · The paper itself

Abstract

objectiveExercise intolerance is a clinical hallmark of chronic conditions. The present study determined pathophysiological mechanisms of exercise intolerance in cardiovascular, neuromuscular, and metabolic disorders.

methodsIn a prospective cross-sectional observational study 152 patients (heart failure reduced ejection fraction, n=32; stroke, n=34; mitochondrial disease, n=28; type two diabetes, n=28; and healthy controls, n=30) performed cardiopulmonary exercise testing with metabolic and haemodynamic measurements. Peak exercise O

resultsExercise tolerance was significantly diminished in patients compared with controls (ie, by 45% stroke, 39% mitochondria disease, and 33% diabetes and heart failure, p<0.05). Cardiac performance was only significantly reduced in heart failure (due to reduced heart rate, stroke volume, and blood pressure) and mitochondrial patients (due reduced stroke volume) compared with controls (ie, by 53% and 26%, p<0.05). Ability of skeletal muscles to extract oxygen (ie, arterial-venous O

conclusionsDifferent mechanisms explain exercise intolerance in patients with heart failure, mitochondrial dysfunction, stroke and diabetes. Their better understanding may improve management of patients, their stress tolerance and quality of life.

Indexed as

cardiac functionexercise limitationsheart failureoxygen consumption

Identifiers

PMID28878952
PMCPMC5574430
OpenAlexW2738100013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.